The Latest Cardiac and Vascular News
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based First-in-Human clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (AlucentNVS) technology. The therapy is […]
A revolutionary device that treats Atrial Fibrillation (AF) – the world’s most common heart rhythm disorder – helps support the healthy aging of BC’s population. April 12, 2022, 9:00 AM Pacific Daylight Time | VANCOUVER, British Columbia – Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the Globe® Mapping and Ablation […]
First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.–(BUSINESS WIRE)–Truvic Medical, Inc., a wholly owned subsidiary of Imperative Care, Inc., today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Prodigy™ Thrombectomy System, designed for the treatment of peripheral […]
HANGZHOU, China, April 11, 2022 /PRNewswire/ — On April 8th, 2022, VenusP-ValveTM, Venus Medtech’s in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, received CE marking under the Medical Devices Regulation (MDR) to be marketed in Europe. Designed to treat patients with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract […]
Sanolla’s pioneering technology draws lifesaving medical insights from listening to bodily sounds that cannot be heard by humans The startup’s AI algorithms provide unmatched disease classification for many cardiopulmonary diseases including COPD, pneumonia, asthma, and cardiac morbidities NESHER, Israel, April 11, 2022 /PRNewswire/ — Israeli startup Sanolla, which provides AI-powered primary care diagnostic solutions, announced […]
April 11, 2022 Strategic 10-year agreement will support large-scale transformation of Oulu University Hospital and their aim to become ‘the smartest hospital in the world’ Philips’ latest diagnostic and interventional solutions and healthcare transformation services will help drive operational efficiency and improved outcomes, while also enhancing the patient and staff experience […]
Anticipates Q4 2022 commercial launch, if approved BURLINGTON, Mass., April 11, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the […]
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system was recognized as one of the winners of the(MDEA), garnering honors in the Cardiovascular Devices category. The ASSURE® WCD system represents the next generation of monitoring and […]
The company plans to develop Lilly’s first-in-class clinical stage anti-angiopoietin-like 3/8 monoclonal antibody for treatment of atherosclerotic cardiovascular disease and potentially other conditions OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kyttaro announces that it has entered into an agreement for the worldwide exclusive license of an anti-angiopoietin-like (ANGPTL) 3/8 monoclonal antibody program […]
~ Acquisition brings highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable our customers’ innovation ~ PLANO, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Today, Integer Holdings Corporation (NYSE: ITGR) announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical (collectively […]
